The peer-reviewed study, entitled “US Cannabis Laws Projected To Cost Generic And Brand Pharmaceutical Firms Billions”, analyzed how publicly traded pharmaceutical firms fared after adult-use or medical marijuana laws were enacted by states. According to Ziemowit Bednarek, California Polytechnic State University’s Finance Department, together with Sarah Stith, pharmaceutical stocks were worth 1.5-2% lower in only 10 days following cannabis legalization.
The incident involving Cost Cannabis in Revelstoke, British Columbia, raises significant questions about pricing strategies…
He emphasized that Trump is likely to pursue descheduling cannabis, which would remove it from…
"How Long Does One Puff of Weed Stay in Your System?"... This topic can be difficult…
GMO x Purple Punch deliver a knockout. The post Sleep through it all with Modified…
As the popularity of CBD (cannabidiol) continues to rise, many pet owners are exploring its…
An intriguing trend has emerged In recent years within the world of professional golf: a…